BaiXiaoAi AI companion for cancer patients in care
Part of Cancer clinical trials.
This study tests a digital helper called BaiXiaoAi that works through the WeChat app to support cancer patients during and after treatment. It may help with managing your care and staying connected to your healthcare team.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be 18 years old or older.
- You must have a cancer diagnosis and be in treatment or getting follow-up care, or you can be the main caregiver for someone with cancer.
- You must be able to read and speak Chinese and know how to use the WeChat app.
- You must be willing to sign a consent form agreeing to take part.
- You must not have a severe mental health condition like schizophrenia or bipolar disorder, or major memory problems that would make it hard to use the app.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether an AI-powered chatbot can help people with cancer feel better emotionally and improve their quality of life. You can join if you are currently in cancer treatment, feeling distressed, and have a smartphone.
This trial tests a mobile app that uses artificial intelligence to help women with early-stage breast cancer manage symptoms during their first chemotherapy. The app is in Arabic and is designed to make it easier to report how you're feeling and get support.
This study tests an AI-powered app that helps breast cancer survivors manage symptoms like fatigue, pain, and sleep problems after treatment. It may help you feel better by giving personalized tips to cope with these symptoms.
This trial tests an AI-assisted program that helps manage cancer care, especially for patients who also have other health conditions. If you join, the program may help coordinate your treatment and monitor your health, possibly leading to better outcomes.
This study is testing a new AI chatbot that gives support after breast cancer treatment. If you join, you'll chat with the bot on Line to help with your recovery.
This trial tests whether an AI-powered management program can improve mental health and daily habits for people with HR+/HER2- breast cancer who are taking CDK4/6 inhibitor pills at home. It is designed to help you feel supported and stay on track with your rehabilitation plan.
Hear when a new Symptoms and Signs trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.